Dividends News 28 November 2025

McDonald’s (MCD) Stock on November 30, 2025: Options Surge, Dividend Hike and Value Push Shape Investor Sentiment

CHICAGO, November 30, 2025 — McDonald’s Corporation (NYSE: MCD) heads into the final month of 2025 with its share price hovering just above $311, sitting a few percentage points below record highs as investors digest strong value‑driven sales, a fresh

30 November 2025

Company Analysis·Dividends·Investing·Options Trading·Stock Market

AbbVie Inc (ABBV) Stock on November 30, 2025: Analyst Downgrade, FDA Wins and Dividend Strength

AbbVie Inc. (NYSE: ABBV) heads into the final month of 2025 with a mixed but generally constructive backdrop for shareholders. The stock is trading in the mid‑$220s per share — around $227 — implying a market capitalization of roughly $400

30 November 2025

Dividends·FDA Updates·Investment Strategies·Pharma News·Stock Analysis

Disney (DIS) Stock News Today, November 30, 2025: Q4 Earnings, Dividend Revival, YouTube TV Deal and New Legal Risks

Walt Disney Company stock is ending November in a strange middle ground: trading around $104–105 per share, comfortably above its 2025 lows but still around 16% below its 52‑week high of $124.69 set in June. MarketWatch Behind that middling share

30 November 2025

Disney News·Dividends·Earnings Reports·Media Industry·Stock Market

Exxon Mobil (XOM) Stock: Dividend Hike, Hydrogen Pivot and Climate Lawsuits Define the Late‑2025 Story

Exxon Mobil Corporation (NYSE: XOM) heads into the final month of 2025 with its share price near record highs, a higher dividend, and a packed agenda of strategic moves—ranging from a paused multibillion‑dollar hydrogen project to fresh climate‑disclosure litigation in

30 November 2025

Climate Change·Corporate News·Dividends·Energy Industry·Stock Market

BitMine Immersion Technologies (BMNR) Stock: New CEO, Dividend and 3% of Ethereum Supply After 80% Crash

BitMine Immersion Technologies, Inc. (NYSE American: BMNR) has become one of 2025’s wildest stories on Wall Street: a former bitcoin miner that morphed into a massive Ethereum treasury vehicle, briefly rocketed 3,000% in a week, attracted billionaire backers – and

30 November 2025

Company News·Cryptocurrency·Dividends·Market Analysis·Stocks

Bristol-Myers Squibb (BMY) Stock on November 29, 2025: 5.4% Dividend, Heavy Institutional Buying and a ‘Hold’ Consensus

Bristol-Myers Squibb (NYSE: BMY) spent Saturday, November 29, 2025 out of the trading spotlight—U.S. markets were closed—but very much in the headlines. A cluster of fresh reports focused on three themes: a fat 5.4% dividend yield, big institutional investors quietly

30 November 2025

Dividends·Institutional Investors·Investment Analysis·Stock Market

PayPal (PYPL) Stock on November 29, 2025: Big-Money Buying, AI Deals, BNPL Expansion and a New Dividend

PayPal Holdings, Inc. (NASDAQ: PYPL) enters the final stretch of 2025 as one of the market’s most hotly debated fintech stocks. The share price is down sharply for the year, yet a wave of institutional money, a landmark AI partnership

29 November 2025

Artificial Intelligence·Dividends·Fintech·Investing·Stock Market

Omnicom Group (OMC) Stock Today: IPG Mega‑Merger, Dividend Hike and Debt Deal Shape 2026 Outlook

Date: November 29, 2025 Omnicom Group Inc. (NYSE: OMC) is entering one of the most important phases in its history. In the space of a few days, the company has: All of this is happening while Omnicom’s share price trades

29 November 2025

Dividends·Financial Analysis·Investment Strategies·Mergers & Acquisitions·Stock Market

Johnson & Johnson (JNJ) Stock Near Record Highs: Today’s News, Earnings, Dividend and Talc Risks – November 29, 2025

On November 29, 2025, Johnson & Johnson (NYSE: JNJ) sits close to record territory after a powerful year-long rally, with Wall Street increasingly treating the healthcare giant as both a growth and defensive name at the same time. The stock

29 November 2025

Dividends·Earnings Reports·Legal Risks·Stock Market

Merck (MRK) Stock Rallies as Big Money Moves In and Dividend Rises – November 28, 2025 Update

On Friday, 28 November 2025, Merck & Co., Inc. (NYSE: MRK) continued to trade near its 52‑week highs as a wave of fresh institutional filings, bullish research notes, and recent oncology approvals kept the spotlight firmly on the pharmaceutical giant.

28 November 2025

Dividends·Financial News·Investing·Pharmaceutical Industry·Stock Market

Exxon Mobil (XOM) Stock on November 28, 2025: Cash Flows, Dividend Hike and Big-Money Moves Explained

Exxon Mobil Corporation (NYSE: XOM) traded around $115–116 per share on Friday, November 28, 2025, leaving the oil major broadly flat to modestly higher for the day as investors digested fresh research on its cash flows, a recently increased dividend,

28 November 2025

Dividends·Financial News·Investment Strategies·Oil and Gas·Stock Analysis

AbbVie Stock (ABBV) Today: Skyrizi’s Canada Win, Dividend Hike and Big-Money Moves — November 28, 2025

AbbVie Inc. (NYSE: ABBV) ended Friday’s session almost unchanged, closing around $227.70 per share, up a negligible 0.02%, after earlier trading slightly in the red. StockAnalysis Even with today’s flat finish, the pharma giant remains one of 2025’s standout healthcare

28 November 2025

Dividends·Investing·Market News·Pharma Industry·Stocks

Dividends News 28 November 2025 - 30 November 2025